Dacarbazine Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with dacarbazine
P
- paclitaxel
- paclitaxel protein-bound
- palifermin
- Pamine FQ (lactobacillus acidophilus / methscopolamine)
- Paraplatin (carboplatin)
- Pediarix (diphtheria toxoid / hepatitis b pediatric vaccine / pertussis, acellular / poliovirus vaccine, inactivated / tetanus toxoid)
- pegaspargase
- pegfilgrastim
- peginterferon beta-1a
- pemetrexed
- Pemfexy (pemetrexed)
- Pemrydi RTU (pemetrexed)
- Penbraya (meningococcal group acwy conjugate-group b vaccine (cvx 316))
- Penetrex (enoxacin)
- Pentacel (diphtheria toxoid / haemophilus b conjugate (prp-t) vaccine / pertussis, acellular / poliovirus vaccine, inactivated / tetanus toxoid)
- pentostatin
- Pepaxto (melphalan flufenamide)
- pertussis, acellular
- pexidartinib
- Pfizer-BioNTech COVID-10 (6m-4y) Vaccine PF (sars-cov-2 mrna (tozinameran 6m-4y) vaccine)
- Pfizer-BioNTech COVID-19 (12y+) Bivalent Booster Vaccine PF (sars-cov-2 (covid-19) mrna (tozinameran 12y+) bivalent booster vaccine)
- Pfizer-BioNTech COVID-19 (12y+) Bivalent Vaccine PF (sars-cov-2 (covid-19) mrna(tozinameran12y+) bivalent vaccine)
- Pfizer-BioNTech COVID-19 (2023-2024) Vaccine PF (cvx 308) (sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 308))
- Pfizer-BioNTech COVID-19 (2023-2024) Vaccine PF (cvx 310) (sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 310))
- Pfizer-BioNTech COVID-19 (5y-11y) Bivalent Booster Vaccine PF (sars-cov-2 (covid-19) mrna (tozinameran 5y-11y) bivalent booster vaccine)
- Pfizer-BioNTech COVID-19 (5y-11y) Bivalent Vaccine PF (sars-cov-2(covid-19)mrna(tozinameran 5y-11y)bivalent vaccine)
- Pfizer-BioNTech COVID-19 (5y-11y) Vaccine PF (sars-cov-2 mrna (tozinameran 5y-11y) vaccine)
- Pfizer-BioNTech COVID-19 (6m-4y) Bivalent Booster Vaccine PF (sars-cov-2 (covid-19) mrna (tozinameran 6m-4y) bivalent booster vaccine)
- Pfizer-BioNTech COVID-19 (6m-4y) Bivalent Vaccine PF (sars-cov-2 (covid-19) mrna (tozinameran 6m-4y) bivalent vaccine)
- Pfizer-BioNTech COVID-19 (6m-4y) Vaccine PF (sars-cov-2 mrna (tozinameran 6m-4y) vaccine)
- Pfizer-BioNTech COVID-19 Vaccine (Do Not Dilute) (sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine)
- Pfizer-BioNTech COVID-19 Vaccine (sars-cov-2 mrna (tozinameran) vaccine)
- Pharmorubicin PFS (epirubicin)
- Pharmorubicin RDF (epirubicin)
- Phillips Colon Health (bifidobacterium infantis / lactobacillus acidophilus)
- Photofrin (porfimer)
- plague vaccine
- Platinol (cisplatin)
- Platinol-AQ (cisplatin)
- Plegridy (peginterferon beta-1a)
- pneumococcal 13-valent vaccine
- pneumococcal 15-valent conjugate vaccine
- pneumococcal 20-valent conjugate vaccine
- pneumococcal 21-valent conjugate vaccine
- pneumococcal 23-polyvalent vaccine
- pneumococcal 7-valent vaccine
- Pneumovax 23 (pneumococcal 23-polyvalent vaccine)
- poliovirus vaccine, inactivated
- poliovirus vaccine, live, trivalent
- ponesimod
- Ponvory (ponesimod)
- porfimer
- PreHevbrio (hepatitis b adult vaccine)
- Prevnar (pneumococcal 7-valent vaccine)
- Prevnar 13 (pneumococcal 13-valent vaccine)
- Prevnar 20 (pneumococcal 20-valent conjugate vaccine)
- Primadophilus Bifidus (bifidobacterium infantis / lactobacillus acidophilus)
- Priorix (measles virus vaccine / mumps virus vaccine / rubella virus vaccine)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Prodigen (bifidobacterium infantis / lactobacillus acidophilus)
- Proleukin (aldesleukin)
- Prolia (denosumab)
- ProQuad (measles virus vaccine / mumps virus vaccine / rubella virus vaccine / varicella virus vaccine)
- Proquin XR (ciprofloxacin)
- Provella (bifidobacterium infantis / lactobacillus acidophilus)
- Provenge (sipuleucel-T)
- Purinethol (mercaptopurine)
- Purixan (mercaptopurine)
- Pyzchiva (ustekinumab)
More about dacarbazine
- dacarbazine consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.